About Us

Business Ethics

Strategic Projects

Initiatives

Useful Links

Members

News

02/2021
Advances in the research and development of therapeutic options witnessed in recent years...
02/2021
There are significant differences in treatment outcomes across European Union member states, and...
02/2021
Thanks to new knowledge and the discovery of new medicines that had previously...

Innovative Pharmaceutical Initiative – iF!

EFPIA/iF! Code on Publication of Data

EFPIA/iF! believes that collaboration between the pharmaceutical industry and healthcare professionals has a significant and positive impact on the quality of patient-centered therapeutic procedures as well as on the value of future research.

EFPIA/iF! believes that collaboration between the pharmaceutical industry and healthcare professionals has a significant and positive impact on the quality of patient-centered therapeutic procedures as well as on the value of future research.

EFPIA/iF! believes that collaboration between the pharmaceutical industry and healthcare professionals has a significant and positive impact on the quality of patient-centered therapeutic procedures and on the value of future research. At the same time, the independence of healthcare professionals in making decisions regarding the prescription or recommendation of a medicine represents one of the fundamental requirements of the healthcare system.

EFPIA/iF! is aware that relationships between pharmaceutical manufacturers and healthcare professionals can potentially lead to suspicions of conflicts of interest, and in recent years there have been increasing demands for greater transparency in these relationships. Therefore, EFPIA/iF! and its members — associations and pharmaceutical manufacturers — have adopted codes and guidelines to ensure adherence to high ethical standards, in line with the expectations of patients, the state or public sector, and other participants in the healthcare system.

Published
5. February 2015.
Source
Category

Latest News

02/2021
Advances in the research and development of therapeutic options witnessed in recent years...
02/2021
There are significant differences in treatment outcomes across European Union member states, and...
02/2021
Thanks to new knowledge and the discovery of new medicines that had previously...
02/2021
Cancer patients are dying from coronavirus – and many will bear the consequences...
02/2021
The annual survey titled “EFPIA Patients WAIT”, conducted by the European Federation of...
02/2021
European organizations involved in oncology health policies have committed to developing and promoting...
02/2021
Lung cancer in Europe kills almost as many people as breast, colorectal, and...
02/2021
Almost forty years ago, the first bone marrow transplant was performed at KBC...
Scroll to Top

About Us

Business Ethics

Strategic Projects

Initiatives

Useful Links

Members

News

02/2021
Advances in the research and development of therapeutic options witnessed in recent years...
02/2021
There are significant differences in treatment outcomes across European Union member states, and...
02/2021
Thanks to new knowledge and the discovery of new medicines that had previously...
Start typing to search